If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.
Duovent Side Effects Reported to FDA
Duovent Side Effect Report#8475096-0 Rosacea, Hyponatraemia, Herpes Zoster, Polychondritis, Oedema Peripheral, Chronic Obstructive Pulmonary Disease, Haemangioma Of Skin
This is a report of a 74-year-old female patient (weight: NA) from Belgium, suffering from the following health symptoms/conditions: NA, who was treated with Duovent (dosage: NA, start time:
Sep 14, 2011), combined with:
Zocor (40 Mg, Qd)
Acetylsalicylzuur (100 Mg, Qd)
Oxygen (1 L, Unk)
Propafenone Hcl (150 Mg, Bid)
Atacand (16 Mg, Qd)
Onbrez (300 Mg, Qd)
and developed a serious reaction and side effect(s): Rosacea, Hyponatraemia, Herpes Zoster, Polychondritis, Oedema Peripheral, Chronic Obstructive Pulmonary Disease, Haemangioma Of Skin after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Duovent treatment in female patients, resulting in Rosacea side effect. The patient was hospitalized.
This report suggests a potential DuoventLacrimation Increased side effect(s) that can have serious consequences. A 44-year-old female patient (weight: NA) from Belgium was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease and used Duovent (dosage: NA) starting
Aug 23, 2011. After starting Duovent the patient began experiencing various side effects, including: Lacrimation Increased, Wheezing, Chest Pain, Feeling Abnormal, Salivary Hypersecretion, Cough, Myocardial Infarction, Rhinorrhoea, DysphagiaAdditional drugs used concurrently:
Sertraline Hydrochloride (100 Mg, Unk)
Lorazepam (1 Mg, Unk)
Onbrez (150 Ug Daily)
Elthyrone (50 Mg, Unk)
Although Duovent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Lacrimation Increased, may still occur.
Duovent Side Effect Report#7933353-8 Respiratory Arrest
This Respiratory Arrest problem was reported by a consumer or non-health professional from Brazil. A 54-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jul 01, 2010 this consumer started treatment with Duovent (dosage: NA). The following drugs were being taken at the same time:
When using Duovent, the patient experienced the following unwanted symptoms/side effects: Respiratory ArrestAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Respiratory Arrest, may become evident only after a product is in use by the general population.
This Blood Pressure Increased side effect was reported by a consumer or non-health professional from . A 57-year-old female patient (weight:NA) experienced the following symptoms/conditions: dyspnoea.The patient was prescribed Duovent (drug dosage: NA), which was initiated on
Jan 01, 2006. Concurrently used drugs:
.After starting to take Duovent the consumer reported adverse symptoms, such as: Blood Pressure Increased, Cardiac Disorder, Dyspnoea, Overdose, Therapeutic Response Decreased, Throat IrritationThese side effects may potentially be related to Duovent. The patient was hospitalized.
This is a report of a 57-year-old female patient (weight: NA) from , suffering from the following health symptoms/conditions: dyspnoea, who was treated with Duovent (dosage: NA, start time:
Jan 01, 2006), combined with:
and developed a serious reaction and side effect(s): Blood Pressure Increased, Cardiac Disorder, Dyspnoea, Overdose, Therapeutic Response Decreased, Throat Irritation after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Duovent treatment in female patients, resulting in Blood Pressure Increased side effect. The patient was hospitalized.
The appearance of Duovent on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.
Why Your Notes are Important
Your notes could be helpful in several ways:
You can use them to remind you of details that may alert your health care professional(s) to a problem
You will have a record to refer to in the future, in case you are ever prescribed the same medicine again
You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.
Medicine Name and Dosage:
Date & Time
Other Medicine(s) or Treatment(s)
Scale: 1 = very mild to 10 = very bad
Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Duovent reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.